Physician profile
Sean Michael Devitt
NPI 1295051381
$2,411.73
in general payments reported to CMS, 2019-2025
16 companies · $830 in 2025
The $830 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,190 · 2022: $122 · 2024: $270 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $390.35 | 2019 | |
| Tepha INC | $379.35 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $216.36 | 2019-2025 | |
| Kls-Martin L.P. | $211.84 | 2019-2025 | |
| Allergan, INC. | $198.19 | 2019-2022 | |
| Motiva USA, LLC | $149.77 | 2025 | |
| Rti Surgical, INC | $146.50 | 2025 | |
| Baxter Healthcare | $139.65 | 2025 | |
| Kerecis Limited | $136.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Cook Medical LLC | $115.93 | 2019 | |
| Sanara Medtech INC. | $110.26 | 2024 | Celleraterx |
| Axogen | $82.79 | 2025 | |
| Abbvie INC. | $82.50 | 2025 | |
| Smith+Nephew, INC. | $23.56 | 2024 | Oasis, Stravix Pl, Grafix Pl |
| My01 INC. | $14.39 | 2025 | My01 Continuous Compartmental Pressure Monitor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $13.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Devitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.